menu search

Life biosciences presents groundbreaking data at arvo demonstrating restoration of visual function in nonhuman primates

Data in a nonhuman primate model of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) demonstrates the ability to restore visual function after...

April 23, 2023, 5:30 pm

Why did pfizer offload this potential mega-blockbuster drug?

Last December, Pfizer formed a new company with Roivant Sciences to trial an experimental IBD medication. The therapy sports a ...

April 23, 2023, 4:45 pm

Here are six new projects looking to mitigate bitcoin mining’s energy footprint

From technical improvement efficiencies to novel market-based solutions, a plethora of projects are try...

April 22, 2023, 4:14 pm

Recruiter.com launches artificial intelligence powered candidate pitch web app

Recruiter.com Group, Inc. (NASDAQ:RCRT), which helps to streamline the hiring process for employers and job seekers alike, revealed that it has beta l...

April 20, 2023, 10:12 am

Google introduces generative ai to create adverts

In a further sign of artificial intelligence (AI) taking over from human workers, Google has announced plans to integrate generative AI into its adver...

April 20, 2023, 9:29 am

Keros therapeutics appoints alpna seth, ph.d., to its board of directors

LEXINGTON, Mass., April 19, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage bio...

April 19, 2023, 12:00 pm

Ensysce ceo dr. lynn kirkpatrick to present featured case study of mpar overdose protection platform accelerated development

~ Global QUOTIENT LIFE SCIENCES Webinar Today, April 19, 2023 at 11:30am ET ~ SAN DIEGO, CA / ACCESSWIRE / April 19, 2023 / Ensysce Biosciences, Inc. ...

April 19, 2023, 9:25 am

Genprex encouraged by latest reports on novel tumor suppressor

Genprex, Inc. (NASDAQ:GNPX) said independent researchers have reported that the tumor suppression gene used in its lead drug candidate REQORSA functio...

April 18, 2023, 11:06 am

Antibodies contract manufacturing market set to reach us$17.5 billion by 2033, says persistence market research

Rising clinical research activities on novel biologics and the burgeoning global demand for personalize...

April 17, 2023, 3:35 pm

$134 million in financial backing for innovative research and ind fillings announced by ocean biomedical (nasdaq: ocea); provides latest updates on advancement of platform, novel discoveries in malari

Providence, RI, April 17, 2023 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (“Ocean”), a biopharma company working to accelerate the development an...

April 17, 2023, 12:01 pm

$134 million in financial backing for innovative research and ind fillings announced by ocean biomedical (nasdaq: ocea); provides latest updates on advancement of platform, novel discoveries in malari

Providence, RI, April 17, 2023 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (“Ocean”), a biopharma company working to accelerate the development an...

April 17, 2023, 12:01 pm

Merck strengthens immunology pipeline with acquisition of prometheus biosciences, inc.

PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions Prometheus Biosciences’ compreh...

April 16, 2023, 10:00 am

Commercial aquaculture vaccines market is projected to reach a revenue of us$ 605.5 million by 2033 | persistence market research

Growing Investments in novel Biologics will propel the overall Market for Commercial Aquaculture Vaccin...

April 13, 2023, 4:25 pm

Axsome therapeutics to report first quarter 2023 financial results on may 8

Axsome to host conference call and webcast on Monday, May 8, 2023, at 8:00 a.m. Eastern Time NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) — Axsome Ther...

April 13, 2023, 11:00 am

Ardelyx presents positive data further supporting efficacy and safety of xphozah® (tenapanor) at national kidney foundation 2023 spring clinical meetings

Three posters support the important role that XPHOZAH, a novel phosphate absorption inhibitor, could po...

April 12, 2023, 8:05 pm

Cti biopharma to participate in two upcoming investor conferences in april 2023

SEATTLE, Wash. , April 12, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development ...

April 12, 2023, 4:30 pm

Aligos therapeutics to present data from chronic hepatitis b and hepatocellular carcinoma programs at the european association for the study of the liver (easl) congress 2023

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company f...

April 11, 2023, 6:50 pm

Kymera therapeutics to report first quarter 2023 financial results on may 4

WATERTOWN, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing ta...

April 11, 2023, 7:00 am

Promis neurosciences submits ind application for alzheimer's treatment

ProMIS Neurosciences (TSX:PMN) told investors it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (...

April 10, 2023, 9:11 am

Back from the dead, ibm's watson ai is alive and re-emerging

While artificial intelligence (AI) seems to have come around full circle in 2023 as ChatGPT finally lit the fuse for full-blown mainstream adoption, I...

April 10, 2023, 8:51 am


Search within

Pages Search Results: